Khalid Hajj is a Principal Scientist in Non-Viral Delivery at Genentech, where they lead teams focused on lipid nanoparticle formulation, analytical, and synthetic chemistry. They previously served as a Senior Scientist at Poseida Therapeutics, where they led LNP formulation discovery for therapeutic programs. Khalid conducted their doctoral research at Carnegie Mellon University, developing lipid nanoparticle formulations for mRNA delivery and gene editing applications. They began their career as an Undergraduate Researcher at the University of Rochester, exploring targeted drug delivery systems. Khalid holds a PhD in Chemical Engineering from Carnegie Mellon University and a Bachelor of Science in Chemical Engineering, Magna Cum Laude, from the University of Rochester.
This person is not in any teams
This person is not in any offices